Healthcare India Podcast | Manipal IPO Explained

Описание: The upcoming Manipal Health Enterprises IPO could be one of the most important healthcare listings in India—but most investors are looking at it the wrong way.

This is not a growth story. Not a turnaround. Not even a margin expansion play. This is a high-efficiency hospital platform already operating at a high degree of maturity.

In this podcast, we cover:
What Manipal is actually selling to investors
Why this IPO is happening at peak operational maturity
Detailed valuation breakdown (₹45K–₹60K Cr range)
Upside vs downside scenarios based on EBITDA sensitivity
Comparison with Apollo Hospitals, Fortis Healthcare, Narayana Health
Key risks no one is talking about
Key Insight:
Growth from here will not come from adding beds—it will come from:
Case mix improvement
Pricing power
Capital allocation discipline

Manipal is not a bet on healthcare demand—it’s a bet on sustaining premium pricing and operational discipline at scale.